UBS AG, London Branch (ESUS)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
UBS AG, London Branch (ESUS). UBS AG, London Branch, through its ETN ESUS, offers investors a leveraged exposure to the MSCI USA ESG Focus Index. This index comprises large- and mid-cap U. S. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 16, 2026UBS AG, London Branch (ESUS) Financial Services Profile
UBS AG, London Branch's ESUS provides a 2x leveraged exposure to the MSCI USA ESG Focus Index, targeting investors seeking amplified returns from ESG-conscious U.S. equities. As an Exchange Traded Note, ESUS carries the credit risk of UBS and is designed for short-term tactical allocation rather than long-term investment due to quarterly rebalancing.
Investment Thesis
ESUS offers a unique investment proposition for investors seeking leveraged exposure to ESG-focused U.S. equities. The 2x leverage factor can potentially amplify returns compared to a non-leveraged ESG index fund. However, the quarterly rebalancing and ETN structure introduce specific risks. The value driver is the performance of the MSCI USA ESG Focus Index, which is influenced by the market's valuation of ESG-compliant companies. Upcoming catalysts include increased investor interest in ESG investing and potential outperformance of ESG-focused companies. Potential risks include the credit risk of UBS, the impact of leverage on losses, and tracking error between the ETN and the underlying index. Given its high beta of 2.04, ESUS is more volatile than the broader market, requiring active monitoring.
Based on FMP financials and quantitative analysis
Key Highlights
- ESUS provides 2x leveraged exposure to the MSCI USA ESG Focus Index, amplifying potential returns and losses.
- The MSCI USA ESG Focus Index screens out companies involved in tobacco, controversial weapons, fossil fuel extraction, and thermal coal power.
- ESUS is structured as an Exchange Traded Note (ETN), exposing investors to the credit risk of UBS AG, London Branch.
- The underlying index rebalances quarterly, making ESUS suitable for short-term tactical allocations.
- ESUS has a beta of 2.04, indicating higher volatility compared to the broader market.
Competitors & Peers
Strengths
- Leveraged exposure to ESG investments.
- Reputable issuer (UBS AG).
- Transparent index methodology.
- Potential for high returns in a rising ESG market.
Weaknesses
- Credit risk of UBS AG.
- Potential for amplified losses due to leverage.
- Quarterly rebalancing may lead to tracking error.
- Higher volatility compared to non-leveraged ESG investments.
Catalysts
- Ongoing: Increasing investor interest in ESG investing.
- Ongoing: Potential outperformance of ESG-focused companies.
- Upcoming: Launch of new ESG-related regulations or incentives.
- Upcoming: Positive research reports on ESG investing.
Risks
- Ongoing: Credit risk of UBS AG.
- Ongoing: Impact of leverage on losses.
- Potential: Tracking error between the ETN and the underlying index.
- Potential: Changes in market sentiment towards ESG investments.
- Potential: Increased volatility in the ESG market.
Growth Opportunities
- Increased Adoption of ESG Investing: The growing awareness and demand for ESG investments present a significant growth opportunity for ESUS. As more investors prioritize ESG factors, the demand for ESG-focused investment products is expected to rise. ESUS, with its leveraged exposure to the MSCI USA ESG Focus Index, can attract investors seeking to amplify their returns from ESG investments. The market size for ESG investments is projected to reach trillions of dollars by 2030, providing a substantial runway for growth.
- Product Innovation and Expansion: UBS AG, London Branch can expand its offerings by introducing new ESG-focused ETNs with different leverage factors or targeting specific ESG themes, such as climate change or social impact. This diversification can attract a broader range of investors and increase the overall assets under management. The timeline for launching new products can be within the next 1-2 years, depending on market demand and regulatory approvals. This would allow UBS to capture a larger share of the growing ESG market.
- Strategic Partnerships and Distribution Channels: Collaborating with financial advisors, wealth management platforms, and institutional investors can enhance the distribution of ESUS and reach a wider audience. Strategic partnerships can provide access to new markets and customer segments. The timeline for establishing these partnerships can be within the next 6-12 months, leading to increased sales and brand awareness. This would allow UBS to leverage existing networks and expertise to promote ESUS.
- Enhanced Marketing and Investor Education: Educating investors about the benefits and risks of leveraged ESG investing can increase the appeal of ESUS. Clear and transparent communication about the ETN structure, index methodology, and potential risks is crucial for building investor confidence. Marketing campaigns can highlight the unique features of ESUS and its potential to generate higher returns. The timeline for implementing these initiatives can be ongoing, with continuous efforts to educate and inform investors.
- Geographic Expansion: While ESUS focuses on the U.S. market, UBS AG, London Branch can explore opportunities to launch similar leveraged ESG ETNs in other regions, such as Europe or Asia. Adapting the index methodology to local market conditions and investor preferences can increase the appeal of these products. The timeline for geographic expansion can be within the next 2-3 years, depending on regulatory approvals and market research. This would allow UBS to diversify its product offerings and tap into new growth markets.
Opportunities
- Growing demand for ESG investments.
- Expansion into new geographic markets.
- Introduction of new ESG-focused ETNs.
- Strategic partnerships with financial advisors.
Threats
- Increased competition from other ESG ETFs and ETNs.
- Changes in ESG regulations and standards.
- Economic downturn impacting ESG investments.
- Negative publicity or reputational damage to UBS AG.
Competitive Advantages
- Brand recognition and reputation of UBS AG.
- Established expertise in structuring and managing ETNs.
- Proprietary index methodology for the MSCI USA ESG Focus Index.
- Distribution network and relationships with financial intermediaries.
About ESUS
UBS AG, London Branch, issues ESUS, an Exchange Traded Note (ETN) that offers a leveraged investment strategy focused on Environmental, Social, and Governance (ESG) factors within the U.S. equity market. ESUS provides a 2x leveraged exposure to the MSCI USA ESG Focus Index, which is designed to represent the performance of companies with high ESG ratings while maintaining a risk profile similar to the broader market. The index methodology involves screening out companies involved in sectors such as tobacco, controversial weapons, fossil fuel extraction, and thermal coal power. The remaining companies are then weighted to maximize ESG exposure while adhering to market-like risk constraints. ESUS is structured as an ETN, meaning it is a debt instrument backed by UBS AG, London Branch. As such, it exposes investors to the credit risk of UBS. The index is rebalanced quarterly, making ESUS suitable for short-term tactical allocations rather than long-term buy-and-hold strategies. The leveraged nature of the ETN can amplify both gains and losses, making it a higher-risk investment product. Investors should carefully consider their risk tolerance and investment objectives before investing in ESUS. UBS AG is a global financial services firm with a significant presence in asset management, wealth management, investment banking, and securities trading. The London Branch plays a key role in UBS's global operations, particularly in the issuance and management of structured products like ESUS.
What They Do
- ESUS provides leveraged exposure to the MSCI USA ESG Focus Index.
- The index tracks large- and mid-cap U.S. companies with strong ESG profiles.
- It screens out companies involved in controversial sectors like tobacco and fossil fuels.
- ESUS is structured as an Exchange Traded Note (ETN) issued by UBS AG, London Branch.
- The ETN offers a 2x leverage factor, amplifying potential returns and losses.
- The underlying index rebalances quarterly.
- ESUS carries the credit risk of UBS AG, London Branch.
Business Model
- ESUS generates revenue for UBS AG, London Branch through management fees.
- UBS also earns revenue from trading and hedging activities related to the ETN.
- The ETN structure allows UBS to raise capital from investors.
- UBS benefits from increased brand awareness and market presence through the issuance of ESUS.
Industry Context
The asset management industry is experiencing significant growth in ESG investing, driven by increasing investor demand for socially responsible and sustainable investment options. The market for ESG-focused investment products is expanding rapidly, with both passive and active strategies gaining traction. ESUS competes with other ESG ETFs and ETNs, but differentiates itself through its leveraged exposure. The competitive landscape includes both large asset managers and specialized ESG investment firms. As of 2026, ESG assets under management are projected to continue their upward trajectory, creating a favorable environment for ESG-focused products like ESUS.
Key Customers
- Retail investors seeking leveraged exposure to ESG investments.
- Institutional investors looking for tactical allocation strategies.
- Financial advisors using ESUS in client portfolios.
- Hedge funds employing ESUS for short-term trading strategies.
Financials
Chart & Info
UBS AG, London Branch (ESUS) stock price: Price data unavailable
Latest News
No recent news available for ESUS.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ESUS.
Price Targets
Wall Street price target analysis for ESUS.
MoonshotScore
What does this score mean?
The MoonshotScore rates ESUS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Common Questions About ESUS
What does ESUS aim to achieve for investors?
ESUS seeks to provide investors with a leveraged return based on the performance of the MSCI USA ESG Focus Index. By employing a 2x leverage factor, ESUS aims to amplify the gains (and losses) experienced by the underlying index, which comprises U.S. companies demonstrating strong environmental, social, and governance practices. The ETN structure allows investors to gain this exposure without directly owning the underlying securities, while also introducing the credit risk of the issuer, UBS AG, London Branch.
How does UBS AG, London Branch, manage the credit risk associated with ESUS?
As the issuer of ESUS, UBS AG, London Branch, is responsible for managing the credit risk associated with the ETN. This involves maintaining a strong credit rating and implementing risk management practices to ensure its ability to meet its obligations to investors. The creditworthiness of UBS is a key factor in determining the value and attractiveness of ESUS, as any deterioration in UBS's financial health could negatively impact the ETN's value. Investors should monitor UBS's credit ratings and financial performance to assess the credit risk associated with ESUS.
What are the potential tax implications of investing in ESUS?
As an Exchange Traded Note (ETN), ESUS is subject to specific tax rules that can differ from those applicable to traditional ETFs or mutual funds. Generally, any gains or losses realized from the sale or redemption of ESUS are treated as capital gains or losses. However, the tax treatment of ETNs can be complex and may vary depending on individual circumstances. Investors should consult with a qualified tax advisor to understand the potential tax implications of investing in ESUS, including the impact of leverage and the ETN structure.
What are the key factors to evaluate for ESUS?
Evaluating ESUS involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Leveraged exposure to ESG investments.. Primary risk to monitor: Ongoing: Credit risk of UBS AG.. This is not financial advice.
How frequently does ESUS data refresh on this page?
ESUS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ESUS's recent stock price performance?
Recent price movement in UBS AG, London Branch (ESUS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Leveraged exposure to ESG investments.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ESUS overvalued or undervalued right now?
Determining whether UBS AG, London Branch (ESUS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ESUS?
Before investing in UBS AG, London Branch (ESUS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for ESUS.
- The information provided is based on available data and may be subject to change.
- Investors should conduct their own due diligence before making any investment decisions.